作者: Ei Vasileiou , C M Turner , R M Montero , G Vergoulas
DOI:
关键词:
摘要: Purinergic signaling is a crucial component of disease whose pathophysiological basis now well established. This review focuses on P2X(7), unique bifunctional purinoreceptor that either opens non selective cation channel or forms large, cytolytic pore depending agonist application and leading to membrane blebbing cell death by necrosis apoptosis.Activation P2X(7) receptor has been shown stimulate the release multiple proinflammatory cytokines activated macrophages, with IL-1b be most extensively studied among them. These findings were verified use knockout ((-/-)) mice.Update information coming from all fields research implicate this at very heart diseases such as rheumatoid arthritis, sclerosis, depression, Alzheimer disease, kidney damage, in renal fibrosis experimental nephritis.Clinical studies are currently underway newly developed antagonists for receptor, results which eagerly anticipated. together data in-vivo experiments mice in-vitro will shed light exciting area.